Accéder au contenu
Merck

Fever and leukocytosis related to terconazole vaginal suppository.

Southern medical journal (1994-07-01)
S S Hyder, J E Manjon, N M Gantz
RÉSUMÉ

We describe a 22-year-old woman who developed fever, shaking chills, and leukocytosis after insertion of a terconazole (80 mg) vaginal suppository for mild vaginal candidiasis. The patient became afebrile and asymptomatic 24 hours after hospital admission without antibiotic therapy. More experience with terconazole is needed before it can be considered as safe as other imidazole derivatives that have been available for more than 15 years.

MATÉRIAUX
Référence du produit
Marque
Description du produit

USP
Terconazole, United States Pharmacopeia (USP) Reference Standard
Supelco
Terconazole, VETRANAL®, analytical standard
Terconazole, European Pharmacopoeia (EP) Reference Standard